The Impact Of Dexmedetomidine With Magnesium Sulfate Versus Magnesium Sulfate Alone on ventricular arrhythmia post Cardiac Surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202502733720861

Enrollment

Registered

2025-02-20

Start date

2023-08-26

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arrythmia post cardiac surgery Cardiology

Interventions

Dexmedetomidine and magnesium sulphate

magnesium sulphate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing elective cardiac surgery Patients ASA III Patients aged 20 – 70 years old lack of prior chronic arrhythmia

Exclusion criteria

Exclusion criteria: Heart rate < 50 bpm (beat per minute), atrioventricular conduction block will be diagnosed by 12 lead ECG Mean arterial pressure <55 mm Hg (despite appropriate volume resuscitation and vasopressors) duration of surgery exceeds 8h (because these patients probably will have complications that won't be representative of the typical cardiac study) Percutaneous mechanical circulatory support (Intraortic balloon -extracorporeal membrane oxygenation.)

Design outcomes

Primary

Measure	Time frame
ventricular arrythmia	—

Secondary

Measure	Time frame
ICU stay 2)Duration of mechanical ventilation 3)Bradycardia HR < 50 bpm and hypotension MAP <55 mm Hg 4)Sedation Score Richmond Agitation Sedation Scale (RASS) will be used in our study	—

Countries

Egypt

Contacts

Public Contactmohammed mourad

assistant prof

mohamed-mourad-80@live.com01006512101

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026